Hancock Whitney Corp Collegium Pharmaceutical, Inc Transaction History

Hancock Whitney Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$21.74 - $25.28 $473,149 - $550,193	-21,764 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$19.25 - $26.1 $57,076 - $77,386	2,965 Added 15.77%	21,764 $516,000
Q4 2020 Feb 09, 2021	BUY	$17.83 - $22.29 $43,309 - $54,142	2,429 Added 14.84%	18,799 $377,000
Q3 2020 Nov 05, 2020	SELL	$15.78 - $20.82 $90,845 - $119,860	-5,757 Reduced 26.02%	16,370 $341,000
Q2 2020 Jul 30, 2020	BUY	$15.49 - $23.51 $5,034 - $7,640	325 Added 1.49%	22,127 $387,000
Q1 2020 May 08, 2020	BUY	$13.89 - $25.45 $70,866 - $129,845	5,102 Added 30.55%	21,802 $356,000
Q4 2019 Feb 06, 2020	BUY	$10.7 - $22.24 $178,690 - $371,408	16,700 New	16,700 $344,000

255

38.6M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.01B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.